1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Anorexiants
Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Route of Administration (Subcutaneous Anorexiants,
Oral Anorexiants)
5.2.2.
By Distribution Channels (Online Pharmacy, Retail
Pharmacy, Hospital Pharmacy)
5.2.3.
By Region
5.2.4. By Company (2023)
5.3.
Market Map
5.3.1. By Route of
Administration
5.3.2. By Distribution
Channels
5.3.3. By Region
6. Asia Pacific
Anorexiants Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Route of
Administration
6.2.2. By Distribution
Channels
6.2.3. By Country
6.3.
Asia Pacific: Country Analysis
6.3.1. China Anorexiants
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Route of Administration
6.3.1.2.2.
By Distribution Channels
6.3.2. India Anorexiants
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Route of Administration
6.3.2.2.2.
By Distribution Channels
6.3.3. Australia
Anorexiants Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Route of Administration
6.3.3.2.2.
By Distribution Channels
6.3.4. Japan Anorexiants
Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Route of Administration
6.3.4.2.2.
By Distribution Channels
6.3.5. South Korea
Anorexiants Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Route of Administration
6.3.5.2.2.
By Distribution Channels
7. Europe Anorexiants
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Route of
Administration
7.2.2. By
Distribution Channels
7.2.3. By
Country
7.3.
Europe: Country Analysis
7.3.1. France Anorexiants
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Route of Administration
7.3.1.2.2.
By Distribution Channels
7.3.2. Germany Anorexiants
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Route of Administration
7.3.2.2.2.
By Distribution Channels
7.3.3. Spain Anorexiants
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Route of Administration
7.3.3.2.2.
By Distribution Channels
7.3.4. Italy Anorexiants
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Route of Administration
7.3.4.2.2.
By Distribution Channels
7.3.5. United Kingdom Anorexiants
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Route of Administration
7.3.5.2.2.
By Distribution Channels
8. North America
Anorexiants Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Route of
Administration
8.2.2. By Distribution
Channels
8.2.3. By Country
8.3.
North America: Country Analysis
8.3.1. United States
Anorexiants Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Route of Administration
8.3.1.2.2.
By Distribution Channels
8.3.2. Mexico Anorexiants
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Route of Administration
8.3.2.2.2.
By Distribution Channels
8.3.3. Canada Anorexiants
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Route of Administration
8.3.3.2.2.
By Distribution Channels
9. South America
Anorexiants Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Route of Administration
9.2.2.
By Distribution Channels
9.2.3. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Anorexiants Market
Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Route of Administration
9.3.1.2.2.
By Distribution Channels
9.3.2. Argentina
Anorexiants Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Route of Administration
9.3.2.2.2.
By Distribution Channels
9.3.3. Colombia Anorexiants
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Route of Administration
9.3.3.2.2.
By Distribution Channels
10. Middle East and
Africa Anorexiants Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Distribution Channels
10.2.3. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa
Anorexiants Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Route of Administration
10.3.1.2.2.
By Distribution Channels
10.3.2. Saudi Arabia
Anorexiants Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Route of Administration
10.3.2.2.2.
By Distribution Channels
10.3.3. UAE Anorexiants
Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Route of Administration
10.3.3.2.2.
By Distribution Channels
10.3.4. Egypt Anorexiants
Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Route of Administration
10.3.4.2.2.
By Distribution Channels
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Anorexiants Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
Competitive Landscape
15.1.
VIVUS, LLC.
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (In case of listed)
15.1.5.
Recent Developments
15.1.6.
SWOT Analysis
15.2. Arena
Pharmaceuticals, Ltd.
15.3. F. Hoffmann-La Roche
Ltd.
15.4. Novo Nordisk A/S
15.5. Currax Pharmaceuticals LLC
15.6. AbbVie Inc.
15.7. ReShape Lifescience Inc.
15.8. Ethicon Inc. (Subsidiary
of Johnson & Johnson).
15.9. Sanofi S.A.
15.10. Medtronic Plc
16. Strategic Recommendations
17. About Us & Disclaimer